GSE146358 dopamine 3 v 4 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE146358_dopamine_3_v_4_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE146358_dopamine_3_v_4_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE146358_dopamine_3_v_4_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE146358_dopamine_3_v_4_human_up.

Results found

Linked to

 

Label

Description

 

Gene

acetylserotonin O-methyltransferase like

Gene

interleukin 3 receptor subunit alpha

Gene

long intergenic non-protein coding RNA 1133

Gene

uncharacterized LOC105371773

Gene

small integral membrane protein 48

Gene

ribosomal protein L23a pseudogene 42

Gene

keratin 16 pseudogene 6

Gene

uncharacterized LOC124909496

Gene

long intergenic non-protein coding RNA 1564

Gene

FXYD6 antisense RNA 1

  • Gene

    acetylserotonin O-methyltransferase like


  • Gene

    interleukin 3 receptor subunit alpha


  • Gene

    long intergenic non-protein coding RNA 1133


  • Gene

    uncharacterized LOC105371773


  • Gene

    small integral membrane protein 48


  • Gene

    ribosomal protein L23a pseudogene 42


  • Gene

    keratin 16 pseudogene 6


  • Gene

    uncharacterized LOC124909496


  • Gene

    long intergenic non-protein coding RNA 1564


  • Gene

    FXYD6 antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.